Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 3
1992 2
1993 7
1994 3
1995 6
1996 5
1997 2
1998 4
1999 6
2000 5
2001 7
2002 9
2003 4
2004 8
2005 12
2006 14
2007 10
2008 15
2009 12
2010 16
2011 12
2012 8
2013 4
2014 5
2015 10
2016 12
2017 5
2018 5
2019 3
2020 2
2021 5
2022 9
2023 2
Text availability
Article attribute
Article type
Publication date

Search Results

216 results
Results by year
Filters applied: . Clear all
Page 1
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. Among authors: racke m. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
LRP4 antibody testing in myasthenia gravis.
Racke MK, Batish SD, Lisak RP, Barohn RJ. Racke MK, et al. J Neuroimmunol. 2022 Oct 15;371:577949. doi: 10.1016/j.jneuroim.2022.577949. Epub 2022 Aug 12. J Neuroimmunol. 2022. PMID: 35973344 No abstract available.
Toll-like receptors in multiple sclerosis.
Racke MK, Drew PD. Racke MK, et al. Curr Top Microbiol Immunol. 2009;336:155-68. doi: 10.1007/978-3-642-00549-7_9. Curr Top Microbiol Immunol. 2009. PMID: 19688333 Free PMC article. Review.
Relapses in multiple sclerosis: Relationship to disability.
Goodin DS, Reder AT, Bermel RA, Cutter GR, Fox RJ, John GR, Lublin FD, Lucchinetti CF, Miller AE, Pelletier D, Racke MK, Trapp BD, Vartanian T, Waubant E. Goodin DS, et al. Among authors: racke mk. Mult Scler Relat Disord. 2016 Mar;6:10-20. doi: 10.1016/j.msard.2015.09.002. Epub 2015 Sep 8. Mult Scler Relat Disord. 2016. PMID: 27063617 Review.
Monoclonal antibody therapies and neurologic disorders.
Novak JC, Lovett-Racke AE, Racke MK. Novak JC, et al. Among authors: racke mk. Arch Neurol. 2008 Sep;65(9):1162-5. doi: 10.1001/archneur.65.9.1162. Arch Neurol. 2008. PMID: 18779418 Review.
Multiple sclerosis--the plaque and its pathogenesis.
Frohman EM, Racke MK, Raine CS. Frohman EM, et al. Among authors: racke mk. N Engl J Med. 2006 Mar 2;354(9):942-55. doi: 10.1056/NEJMra052130. N Engl J Med. 2006. PMID: 16510748 Review. No abstract available.
Pharmacological treatment of early multiple sclerosis.
Stüve O, Bennett JL, Hemmer B, Wiendl H, Racke MK, Bar-Or A, Hu W, Zivadinov R, Weber MS, Zamvil SS, Pacheco MF, Menge T, Hartung HP, Kieseier BC, Frohman EM. Stüve O, et al. Among authors: racke mk. Drugs. 2008;68(1):73-83. doi: 10.2165/00003495-200868010-00005. Drugs. 2008. PMID: 18081373 Review.
216 results